BiotechTube

gabapentin 600 mg + gabapentin 1200 mg + gabapentin 1800 mg + diazepam 20 mg

ApprovedCompleted
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Abuse Potential

Conditions

Abuse Potential

Trial Timeline

Mar 29, 2021 → Nov 10, 2022

NCT ID
NCT04570436

About gabapentin 600 mg + gabapentin 1200 mg + gabapentin 1800 mg + diazepam 20 mg

gabapentin 600 mg + gabapentin 1200 mg + gabapentin 1800 mg + diazepam 20 mg is a approved stage product being developed by Viatris for Abuse Potential. The current trial status is completed. This product is registered under clinical trial identifier NCT04570436. Target conditions include Abuse Potential.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT04570436ApprovedCompleted

Competing Products

15 competing products in Abuse Potential

See all competitors
ProductCompanyStageHype Score
atomoxetine + placeboEli LillyPhase 2
52
Placebo + Active Comparator #1 + Active Comparator #2 + Active Comparator #3 + Lorcaserin Dose #1 + Lorcaserin Dose #2 + Lorcaserin Dose #3EisaiPhase 1
33
Istradefylline + Phentermine 45 mgKyowa KirinPhase 1
33
Tapentadol IR + Oxycodone IRJohnson & JohnsonPre-clinical
23
TC-5214 + TC-5214 Placebo + Ketamine + Phentermine + TC-5214 + TC-5214 + PhentermineAstraZenecaPhase 1
33
Aprepitant 0mg + Aprepitant 40mg + Aprepitant 200mg + Oxycodone 0mg, p.o. + Oxycodone 20mg, p.o. + Oxycodone 40mg, p.o. + Oxycodone 0mg, IN + Oxycodone 15mg, IN + Oxycodone 30mg, INMerckPre-clinical
23
Placebo + EMBEDA - morphine sulfate/ naltrexone hydrochloride + morphine sulfate CR crushed.PfizerPhase 1
32
40/0mg taken first + 80/0mg taken first + 40/240mg taken first + 80/480mg taken first + 0/0mg taken firstPfizerPhase 2
51
Placebo + MS Contin (morphine sulfate, controlled release) + EMBEDA (morphine sulfate / naltrexone hydrochloride)PfizerPhase 1
32
Pregabalin 300mg + pregabalin 450 mg + Pregabalin 300 mg with oxycodone 20 mg + pregabalin 450 mg with oxycodone 20 mg + oxycodone 20 mg + PlaceboViatrisApproved
82
gabapentin 600 mg + gabapentin 1200 mg + gabapentin 600 mg and oxycodone HCl 20 mg + gabapentin 1200 mg and oxycodone HCl 20 mg + oxycodone HCl 20 mg + placeboViatrisApproved
82
Sativex + Sativex + Sativex + Placebo + Marinol + MarinolJazz PharmaceuticalsPhase 1
30
ALKS 33-BUP + ALKS 33 + PlaceboAlkermesPhase 1
30
pioglitazoneOmeros CorporationPhase 2
47
MN-166 (50 mg) First + Placebo FirstMediciNovaPhase 2
44

Other Products from Viatris

Revefenacin + Tiotropium + Revefenacin Placebo + Tiotropium PlaceboApproved
82
PregabalinApproved
82
Imiquimod + DiclofenacApproved
82
Sulfamylon® For 5 % Topical Solution + Topical Antimicrobial/Antifungal MedicationsApproved
82
FlecainideApproved
82